-
Phase 3 CF Trial on AeroVanc for MRSA Infection Updates Enrollment Info
Enrollment for a Phase 3 clinical trial testing AeroVanc in CF patients with MRSA lung infection is expected to be completed in the third quarter of 2019. Read more about it here.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.